Abstract
MicroRNAs (miRs) have been shown to be differentially expressed in the serum of cancer patients and controls, and can thus be used as biomarkers for cancer screening. We detected the expression level of miR-155 in the serum of female breast cancer patients and healthy controls to investigate whether serum miR-155 could discriminate patients with early-stage breast cancer. Serum samples were collected from 20 female patients with newly diagnosed breast cancer and 10 healthy controls. Real-time quantitative PCR was used to detect the expression level of miR-155. The expression level of miR-155 was significantly increased in the serum of breast cancer patients compared with in the serum of normal controls. MiR-155 may be useful as a blood-based biomarker for breast cancer screening.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Schaeffer P, Mulcahy H E, Meyer P, et al. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin Cancer Res, 2000, 6: 3823–3826
Lee R C, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science, 2001, 294: 862–864
Lee R C, Feinbaum R L, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75: 843–854
Calin G A, Croce C M. MicroRNA signatures in human cancers. Nat Rev Cancer, 2006, 6: 857–866
Kim V N, Nam J W. Genomics of microRNA. Trends Genet, 2006, 22: 165–173
Sotiropoulou G, Pampalakis G, Lianidou E, et al. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA, 2009, 15: 1443–1461
Iorio M V, Ferracin M, Liu C G, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res, 2005, 65: 7065–7070
Mitchell P S, Parkin R K, Kroh E M, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA, 2008, 105: 10513–10518
Ng E K, Chong W W, Jin H, et al. Differential expression of microRNAs in plasma of colorectal cancer patients: A potential marker for colorectal cancer screening. Gut, 2009, 58: 1375–1381
Zhu W Z, Qin W Y, Ulus A, et al. Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes, 2009, 2: 89
Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008, 10: 1038
Israel A, Sharan R, Ruppin E, et al. Increased microRNA activity in human cancers. PLoS One, 2009, 4: 6045
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Zhao, S., Wu, Q., Gao, F. et al. Serum microRNA-155 as a potential biomarker for breast cancer screening. Chin. Sci. Bull. 57, 3466–3468 (2012). https://doi.org/10.1007/s11434-012-5362-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-012-5362-1